Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
The Journal of Cell Biology
|
June 14, 2006
HURP controls spindle dynamics to promote proper interkinetochore tension and efficient kinetochore capture
Jim Wong, Guowei Fang
Methods in Molecular Biology (Clifton, N.J.)
|
June 10, 2004
A Xenopus cell-free system for analysis of the Chfr ubiquitin ligase involved in control of mitotic entry
Dongmin Kang, Jim Wong, Guowei Fang
The Journal of Cell Biology
|
January 25, 2002
The checkpoint protein Chfr is a ligase that ubiquitinates Plk1 and inhibits Cdc2 at the G2 to M transition
Dongmin Kang, James Chen, Jim Wong, et al.
Molecular Biology of the Cell
|
March 7, 2008
Aurora A regulates the activity of HURP by controlling the accessibility of its microtubule-binding domain
Jim Wong, Robert Lerrigo, Chang-Young Jang, et al.
The Journal of Cell Biology
|
April 16, 2008
DDA3 recruits microtubule depolymerase Kif2a to spindle poles and controls spindle dynamics and mitotic chromosome movement
Chang-Young Jang, Jim Wong, Judith A Coppinger, et al.
Critical Care Medicine
|
September 23, 2009
Gene expression profiling: classification of mice with left ventricle systolic dysfunction using microarray analysis
Jim Wong, Christine Chang, Rani Agrawal, et al.
The Journal of Experimental Medicine
|
January 16, 2020
Mutation position is an important determinant for predicting cancer neoantigens
Aude-Hélène Capietto, Suchit Jhunjhunwala, Samuel B Pollock, et al.
Cancer Discovery
|
May 1, 2024
A Next-Generation BRAF Inhibitor Overcomes Resistance to BRAF Inhibition in Patients with BRAF-Mutant Cancers Using Pharmacokinetics-Informed Dose Escalation
Rona Yaeger, Meredith A McKean, Rizwan Haq, et al.
Journal of Medicinal Chemistry
|
August 1, 2024
Discovery of Pyrazolopyrazines as Selective, Potent, and Mutant-Active MET Inhibitors with Intracranial Efficacy
Quinn A Bumpers, Robert W Pipal, Anna M Benz-Weeden, et al.
ACS Medicinal Chemistry Letters
|
February 19, 2025
Design of Potent Menin-KMT2A Interaction Inhibitors with Improved <i>In Vitro</i> ADME Properties and Reduced hERG Affinity
Bruno D Chapsal, Jennifer R Kimbrough, Stephanie M Bester, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
The Journal of Cell Biology
|
June 14, 2006
HURP controls spindle dynamics to promote proper interkinetochore tension and efficient kinetochore capture
Jim Wong, Guowei Fang
Methods in Molecular Biology (Clifton, N.J.)
|
June 10, 2004
A Xenopus cell-free system for analysis of the Chfr ubiquitin ligase involved in control of mitotic entry
Dongmin Kang, Jim Wong, Guowei Fang
The Journal of Cell Biology
|
January 25, 2002
The checkpoint protein Chfr is a ligase that ubiquitinates Plk1 and inhibits Cdc2 at the G2 to M transition
Dongmin Kang, James Chen, Jim Wong, et al.
Molecular Biology of the Cell
|
March 7, 2008
Aurora A regulates the activity of HURP by controlling the accessibility of its microtubule-binding domain
Jim Wong, Robert Lerrigo, Chang-Young Jang, et al.
The Journal of Cell Biology
|
April 16, 2008
DDA3 recruits microtubule depolymerase Kif2a to spindle poles and controls spindle dynamics and mitotic chromosome movement
Chang-Young Jang, Jim Wong, Judith A Coppinger, et al.
Critical Care Medicine
|
September 23, 2009
Gene expression profiling: classification of mice with left ventricle systolic dysfunction using microarray analysis
Jim Wong, Christine Chang, Rani Agrawal, et al.
The Journal of Experimental Medicine
|
January 16, 2020
Mutation position is an important determinant for predicting cancer neoantigens
Aude-Hélène Capietto, Suchit Jhunjhunwala, Samuel B Pollock, et al.
Cancer Discovery
|
May 1, 2024
A Next-Generation BRAF Inhibitor Overcomes Resistance to BRAF Inhibition in Patients with BRAF-Mutant Cancers Using Pharmacokinetics-Informed Dose Escalation
Rona Yaeger, Meredith A McKean, Rizwan Haq, et al.
Journal of Medicinal Chemistry
|
August 1, 2024
Discovery of Pyrazolopyrazines as Selective, Potent, and Mutant-Active MET Inhibitors with Intracranial Efficacy
Quinn A Bumpers, Robert W Pipal, Anna M Benz-Weeden, et al.
ACS Medicinal Chemistry Letters
|
February 19, 2025
Design of Potent Menin-KMT2A Interaction Inhibitors with Improved <i>In Vitro</i> ADME Properties and Reduced hERG Affinity
Bruno D Chapsal, Jennifer R Kimbrough, Stephanie M Bester, et al.
Page
of 1